Marshall Fordyce - 13 May 2021 Form 3 Insider Report for Vera Therapeutics, Inc. (VERA)

Role
President and CEO, Director
Signature
/s/ Joseph R. Young, Attorney-in-Fact
Issuer symbol
VERA
Transactions as of
13 May 2021
Net transactions value
$0
Form type
3
Filing time
13 May 2021, 19:00:28 UTC
Next filing
18 Feb 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding VERA Class A Common Stock 137,400 13 May 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding VERA Stock Option (right to buy) 13 May 2021 Class A Common Stock 5,669 $2.32 Direct F1
holding VERA Stock Option (right to buy) 13 May 2021 Class A Common Stock 1,107,212 $2.90 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 1/3 of the shares subject to the option vested on January 10, 2021, and 1/36 of the shares vest monthly thereafter. The original grant for 9,277 shares was exercised for 3,607 shares on April 8, 2021.
F2 1/4 of the shares subject to the option vest on December 16, 2021, and 1/48 of the shares vest monthly thereafter.